Rare Pathogenic Variants in Mitochondrial and Inflammation-Associated Genes May Lead to Inflammatory Cardiomyopathy in Chagas Disease
暂无分享,去创建一个
A. Ribeiro | C. Cardoso | C. L. Oliveira | L. Abel | M. C. Nunes | C. Mady | B. Ianni | J. Kalil | M. Torres | E. Sabino | S. Marquet | E. Cunha-Neto | A. Cobat | D. Levy | A. Frade | L. R. Ferreira | V. O. Rigaud | C. Chevillard | P. Andrieux | Ariela Mota Ferreira | D. Candido | L. C. Oliveira | P. Buck | R. R. Almeida | R. Zaniratto | J. P. Nunes | M. Ouarhache | F. Gallardo | Sergio Bydlowsky | O. R. Santos-Junior | A. M. Ferreira | A. Ferreira
[1] H. Nakaya,et al. miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy , 2020, PLoS neglected tropical diseases.
[2] P. Wipf,et al. ETHE1 and MOCS1 deficiencies: Disruption of mitochondrial bioenergetics, dynamics, redox homeostasis and endoplasmic reticulum-mitochondria crosstalk in patient fibroblasts , 2019, Scientific Reports.
[3] P. Matarrese,et al. Inflammatory cytokines associated with cancer growth induce mitochondria and cytoskeleton alterations in cardiomyocytes , 2019, Journal of cellular physiology.
[4] I. Blasig,et al. Doxorubicin‐induced cardiotoxicity involves IFNγ‐mediated metabolic reprogramming in cardiomyocytes , 2019, The Journal of pathology.
[5] S. Priori,et al. Dilated cardiomyopathy , 1992, Nature reviews. Disease primers.
[6] J. Kalil,et al. Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy , 2018, Front. Immunol..
[7] R. Tian,et al. Mitochondrial dysfunction in pathophysiology of heart failure , 2018, The Journal of clinical investigation.
[8] H. Tanowitz,et al. Pathogenesis of Chronic Chagas Disease: Macrophages, Mitochondria, and Oxidative Stress , 2018, Current Clinical Microbiology Reports.
[9] E. Bocchi,et al. Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment. , 2017, Journal of the American College of Cardiology.
[10] Christophe Béroud,et al. Exome Sequencing Identifies Two Variants of the Alkylglycerol Monooxygenase Gene as a Cause of Relapses in Visceral Leishmaniasis in Children, in Sudan , 2017, The Journal of infectious diseases.
[11] Steven B Marston,et al. Obscurin variants and inherited cardiomyopathies , 2017, Biophysical Reviews.
[12] J. Casanova,et al. Autosomal Recessive Cardiomyopathy Presenting as Acute Myocarditis. , 2017, Journal of the American College of Cardiology.
[13] M. González-Gay,et al. Leptin in the interplay of inflammation, metabolism and immune system disorders , 2017, Nature Reviews Rheumatology.
[14] J. Finsterer,et al. Therapeutic Advances in Gastroenterology , 2022 .
[15] John G Doench,et al. A Genome-wide CRISPR Death Screen Identifies Genes Essential for Oxidative Phosphorylation. , 2016, Cell metabolism.
[16] A. Ribeiro,et al. Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile , 2016, BMJ Open.
[17] Y. Okazaki,et al. A Comprehensive Genomic Analysis Reveals the Genetic Landscape of Mitochondrial Respiratory Chain Complex Deficiencies , 2016, PLoS genetics.
[18] D. Lacroix,et al. From cardiac mitochondrial dysfunction to clinical arrhythmias. , 2015, International journal of cardiology.
[19] J. Finsterer,et al. Cardiac manifestations of primary mitochondrial disorders. , 2014, International journal of cardiology.
[20] E. Victor,et al. Interferon-gamma induced cell death: Regulation and contributions of nitric oxide, cJun N-terminal kinase, reactive oxygen species and peroxynitrite. , 2014, Biochimica et biophysica acta.
[21] M. Soares,et al. Tissue damage control in disease tolerance. , 2014, Trends in immunology.
[22] E. Bocchi,et al. Myocardial Gene Expression of T-bet, GATA-3, Ror-γt, FoxP3, and Hallmark Cytokines in Chronic Chagas Disease Cardiomyopathy: An Essentially Unopposed TH1-Type Response , 2014, Mediators of inflammation.
[23] A. Ribeiro,et al. Electrocardiographic Abnormalities in Elderly Chagas Disease Patients: 10‐Year Follow‐Up of the Bambuí Cohort Study of Aging , 2014, Journal of the American Heart Association.
[24] Paul H. Goldspink,et al. Could interferon-gamma be a therapeutic target for treating heart failure? , 2014, Heart Failure Reviews.
[25] T. Suuronen,et al. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. , 2013, Cellular signalling.
[26] F. Lombardi,et al. Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[27] S. Ekker,et al. Trapping Cardiac Recessive Mutants via Expression-Based Insertional Mutagenesis Screening , 2013, Circulation research.
[28] T. Uchiumi,et al. Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction , 2012, Bioscience reports.
[29] B. Funke,et al. Dilated cardiomyopathy , 2007, Archives of Disease in Childhood.
[30] N. Garg,et al. Defects of mtDNA Replication Impaired Mitochondrial Biogenesis During Trypanosoma cruzi Infection in Human Cardiomyocytes and Chagasic Patients: The Role of Nrf1/2 and Antioxidant Response , 2012, Journal of the American Heart Association.
[31] B. Berk,et al. G protein coupled receptor kinase 2 interacting protein 1 (GIT1) is a novel regulator of mitochondrial biogenesis in heart. , 2011, Journal of molecular and cellular cardiology.
[32] N. Stolf,et al. Selective Decrease of Components of the Creatine Kinase System and ATP Synthase Complex in Chronic Chagas Disease Cardiomyopathy , 2011, PLoS neglected tropical diseases.
[33] B. Ianni,et al. Avaliação do metabolismo dos fosfatos de alta energia em pacientes com doença de Chagas , 2010 .
[34] R. Weiss,et al. Evaluation of the metabolism of high energy phosphates in patients with Chagas' disease. , 2010, Arquivos brasileiros de cardiologia.
[35] M. Fresno,et al. IFN-γ-Induced TNF-α Expression Is Regulated by Interferon Regulatory Factors 1 and 8 in Mouse Macrophages1 , 2008, The Journal of Immunology.
[36] M. Fresno,et al. IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. , 2008, Journal of immunology.
[37] S. I. Park,et al. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN. , 2007, Journal of molecular biology.
[38] P. Allen,et al. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. , 2005, The American journal of pathology.
[39] C. Long,et al. Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo , 2001, Pflügers Archiv.
[40] C. Mady,et al. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. , 2001, Journal of autoimmunity.
[41] D. Rabier,et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. , 1999, Circulation.
[42] João Pimenta,et al. Evolução clínica a longo prazo, correlacionando a presença de bloqueios da condução intraventricular em pacientes chagásicos e não chagásicos assintomáticos , 1999 .
[43] J. Pimenta,et al. [Long-term follow up of asymptomatic chagasic individuals with intraventricular conduction disturbances, correlating with non-chagasic patients]. , 1999, Revista da Sociedade Brasileira de Medicina Tropical.
[44] R. Chuit,et al. Risk of death due to chronic chagasic cardiopathy. , 1999, Memorias do Instituto Oswaldo Cruz.
[45] H. Gonzalez,et al. Echocardiographic and Clinical Predictors of Mortality in Chronic Chagas' Disease , 1998, Echocardiography.
[46] F. Pileggi,et al. Anin SituQuantitative Immunohistochemical Study of Cytokines and IL-2R+in Chronic Human Chagasic Myocarditis: Correlation with the Presence of MyocardialTrypanosoma cruziAntigens , 1997 .
[47] G. Baroldi,et al. Sudden and unexpected death in clinically 'silent' Chagas' disease. A hypothesis. , 1997, International journal of cardiology.
[48] F. Pileggi,et al. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. , 1997, Clinical immunology and immunopathology.
[49] J. Aliberti,et al. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages , 1995, Infection and immunity.
[50] D. Dávila,et al. Electrocardiographic abnormalities and left ventricular systolic function in Chagas' heart disease. , 1990, International journal of cardiology.
[51] F. Pileggi,et al. The Role of active myocarditis in the development of heart failure in chronic chagas' disease: A study based on endomyocardial biopsies , 1987, Clinical cardiology.
[52] Miyazawa Shoko,et al. Reduction of β-oxidation capacity of rat liver mitochondria by feeding orotic acid , 1982 .
[53] T. Hashimoto,et al. Reduction of beta-oxidation capacity of rat liver mitochondria by feeding orotic acid. , 1982, Biochimica et biophysica acta.